Agreement to provide up to $2.5 million CAD to Conavi Medical to support the commercial launch of the next-generation Novasight Hybrid system ...
― Announced encouraging results in July 2025 from the 12 mg dose cohort of the Phase 1b PIONEER trial of pociredir in sickle cell disease (SCD) ― ― Enrollment complete in the 20 mg dose cohort (n=12) ...
Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases, today announced that the ...
Aeluma, Inc. (NASDAQ:ALMU), a semiconductor company specializing in high-performance, scalable technologies for mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum computing, ...
Conference Call Scheduled for November 5, 2025, at 4:30 p.m. ET ...
Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) ('Electra” or the 'Company”) is pleased to announce the appointment of Paolo Toscano, P.Eng., as Vice President, Projects and ...
EVERETT, Wash., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Coastal Financial Corporation (Nasdaq: CCB) (the "Company”, "Coastal", "we", "our", or "us"), the holding company ...
Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) ('Verano” or the 'Company”), a leading multi-state cannabis company, today announced its financial results for the third quarter ended September 30 ...
Total Operating Expenses: For Q3 2025, total operating expenses decreased $8.1 million, or 20%, compared with Q3 2024, due primarily to the impact of the June 2025 operational restructuring. Excluding ...
Lifecore to Execute Commercial Site Transfer and Become New Supplier of Choice for Leading Commercial Injectable Pharmaceutical Product ...
For the third quarter of 2025, gross margin was 76.6%, up from 74.9% for the third quarter of 2024, and up from 74.2% in the second quarter of 2025. Net income for the quarter was $0.7 million, or ...
ThreeD Capital Inc. ('ThreeD' or the 'Company') (CSE:IDK) (OTCQX:IDKFF), a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results